(Q43684198)

25 November 2017

title

Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. (English)

1 reference

inflammatory bowel diseases

25 November 2017

main subject

1 reference

Romagnuolo J

1

1 reference

25 November 2017

Fedorak RN

2

1 reference

25 November 2017

Dias VC

3

1 reference

25 November 2017

Bamforth F

4

1 reference

25 November 2017

Teltscher M

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

The American Journal of Gastroenterology

25 November 2017

published in

1 reference

25 November 2017

volume

96

1 reference

25 November 2017

issue

7

1 reference

25 November 2017

page(s)

2143-2149

1 reference

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Transdermal nicotine for active ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03950.X

10.1111/J.1572-0241.2001.03950.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference